Overview

Price chart · mood · technical indicators

MRM

Medirom Healthcare Technologies Incstock Consumer Cyclical

Personal Services

$1.2262.02%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$0.72$4.45

Current: $1.22

Market Comparison

vs Consumer Cyclical Sector & Personal Services Industry

MRM

+62.02%

1Y Performance

Fundamentals

Updated daily after market close

P/E ratio3.30

EPS (TTM)$0.3727.8% YoY

Profit margin0.5%CONSUMER CYCLICAL

Market cap$9.6MMicro cap

Valuation

Forward P/E: —
PEG ratio: —
P/B: 6.34
P/S (TTM): 0.00
EV/EBITDA: 15.81

Profitability & growth

ROE (TTM): 53.2%
Operating margin: -25.8%
Revenue growth YoY: -6.7%
Dividend yield: —
Beta: 1.03

Last earnings

Oct 21, 2025 · Estimate $0.00 · Reported $-87.38

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Medirom Healthcare Technologies Inc

Company profile

MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.

Classification

Sector: Consumer Cyclical
Industry: Personal Services
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 2-3-1 DAIBA, TOKYO, JAPAN
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$9.6M

Shares outstanding$7.9M

52W high$3.53

52W low$0.72

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

MRM

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Medirom Delays 20-F Yearly Report Filing

MEDIROM Calls May 29 Shareholder Meeting to Approve FY2025 Results and Expand Board

Medirom Healthcare Technologies schedules annual shareholder meeting for May 29

MEDIROM Calls May 29 Shareholder Meeting to Approve FY2025 Results and Expand Board

Healthcare Technologies Inc. (MRM) details 2025 results and new convertible bonds

MEDIROM Extends Loan Maturity with Kufu to April 30, 2026

Healthcare Technologies (MRM) pushes loan maturity to April 30, 2026

Kufu boosts Medirom (MRM) stake with JPY 275M convertible bonds

MRM Should I Buy

Medirom (MRM) director Ogawa Tomoya reports holding 28,500 common shares

Medirom Healthcare Technologies Inc share price

Medirom (MRM) CFO Fujiwara Fumitoshi reports holding 40,000 shares

Medirom (MRM) director Nojima Akira reports holding 1,200 common shares

Medirom (MRM) CEO Eguchi Kouji discloses initial share and option holdings

MEDIROM Launches Partnership with Tools for Humanity in Accessibility: Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

3,000 Orb locations in Japan could bring MEDIROM $39M pre-tax

MEDIROM Launches Partnership with Tools for Humanity in

MEDIROM Seals Tools for Humanity Deal, Targets $39 Million from Orb Rollout in Japan

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

About Medirom Healthcare Technologies Inc

Classification

Company profile

MRM

Market Comparison

MRM Market Analysis

Overview

MRM

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Medirom Delays 20-F Yearly Report Filing

MEDIROM Calls May 29 Shareholder Meeting to Approve FY2025 Results and Expand Board

Medirom Healthcare Technologies schedules annual shareholder meeting for May 29

MEDIROM Calls May 29 Shareholder Meeting to Approve FY2025 Results and Expand Board

Healthcare Technologies Inc. (MRM) details 2025 results and new convertible bonds

MEDIROM Extends Loan Maturity with Kufu to April 30, 2026

Healthcare Technologies (MRM) pushes loan maturity to April 30, 2026

Kufu boosts Medirom (MRM) stake with JPY 275M convertible bonds

MRM Should I Buy

Medirom (MRM) director Ogawa Tomoya reports holding 28,500 common shares

Medirom Healthcare Technologies Inc share price

Medirom (MRM) CFO Fujiwara Fumitoshi reports holding 40,000 shares

Medirom (MRM) director Nojima Akira reports holding 1,200 common shares

Medirom (MRM) CEO Eguchi Kouji discloses initial share and option holdings

MEDIROM Launches Partnership with Tools for Humanity in Accessibility: Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

3,000 Orb locations in Japan could bring MEDIROM $39M pre-tax

MEDIROM Launches Partnership with Tools for Humanity in

MEDIROM Seals Tools for Humanity Deal, Targets $39 Million from Orb Rollout in Japan

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

About Medirom Healthcare Technologies Inc

Classification

Company profile

MRM

Market Comparison